BioCentury
ARTICLE | Company News

PeptiDream, Eli Lilly deal

January 6, 2014 8:00 AM UTC

On Dec. 19, 2013, the companies partnered to identify macrocyclic peptides as potential drugs for undisclosed targets being pursued by Lilly. PeptiDream will use its Peptide Discovery Platform System ...